X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4024) 4024
Book Review (795) 795
Publication (197) 197
Magazine Article (30) 30
Conference Proceeding (13) 13
Book Chapter (8) 8
Web Resource (8) 8
Newsletter (7) 7
Dissertation (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3647) 3647
humans (3524) 3524
sulfonylurea compounds - therapeutic use (2770) 2770
diabetes mellitus, type 2 - drug therapy (2143) 2143
hypoglycemic agents - therapeutic use (2071) 2071
male (1991) 1991
female (1868) 1868
middle aged (1633) 1633
aged (1314) 1314
endocrinology & metabolism (1080) 1080
adult (979) 979
type 2 diabetes (948) 948
insulin - therapeutic use (898) 898
metformin - therapeutic use (871) 871
diabetes (828) 828
diabetes mellitus, type 2 - blood (741) 741
diabetes mellitus - drug therapy (706) 706
drug therapy, combination (706) 706
insulin (676) 676
sulfonylurea compounds - adverse effects (653) 653
hypoglycemic agents - adverse effects (631) 631
metformin (628) 628
blood glucose - metabolism (625) 625
animals (563) 563
hypoglycemic agents - administration & dosage (533) 533
sulfonylurea compounds - administration & dosage (516) 516
pharmacology & pharmacy (508) 508
treatment outcome (477) 477
abridged index medicus (462) 462
mellitus (453) 453
sulfonylurea (447) 447
sulfonylurea compounds - pharmacology (415) 415
glucose (413) 413
thiazolidinediones - therapeutic use (395) 395
medicine, general & internal (385) 385
glycemic control (381) 381
administration, oral (365) 365
diabetes mellitus, type 2 - complications (365) 365
diabetes mellitus (362) 362
glycated hemoglobin a - metabolism (361) 361
risk factors (360) 360
hypoglycemic agents - pharmacology (359) 359
hypoglycemic agents (351) 351
blood glucose - analysis (349) 349
drug therapy (345) 345
care and treatment (332) 332
glimepiride (327) 327
hypoglycemia - chemically induced (320) 320
blood glucose - drug effects (313) 313
insulin - blood (305) 305
sulfonylureas (305) 305
time factors (305) 305
sulfonylurea compounds (304) 304
diabetes therapy (293) 293
hypoglycemia (293) 293
insulin - metabolism (285) 285
glycated hemoglobin a - analysis (280) 280
therapy (278) 278
glyburide - therapeutic use (272) 272
risk (268) 268
glibenclamide (263) 263
internal medicine (263) 263
analysis (260) 260
research (253) 253
insulin secretion (251) 251
rats (250) 250
diabetes mellitus, type 2 - physiopathology (248) 248
insulin resistance (248) 248
aged, 80 and over (245) 245
double-blind method (242) 242
diabetes mellitus, type 2 - metabolism (241) 241
dipeptidyl-peptidase iv inhibitors - therapeutic use (239) 239
biguanides - therapeutic use (236) 236
mortality (234) 234
retrospective studies (229) 229
thiazolidinediones (227) 227
hyperglycemia (226) 226
type 2 diabetes mellitus (226) 226
metformin - administration & dosage (223) 223
double-blind (214) 214
medicine & public health (199) 199
health aspects (194) 194
adolescent (193) 193
metformin - adverse effects (184) 184
complications (182) 182
dose-response relationship, drug (177) 177
body mass index (170) 170
cohort studies (170) 170
efficacy (169) 169
insulin - administration & dosage (169) 169
dextrose (166) 166
clinical trials (164) 164
clinical trials as topic (164) 164
management (164) 164
hypoglycemic sulfonylureas (163) 163
type-2 diabetes-mellitus (161) 161
follow-up studies (159) 159
gliclazide - therapeutic use (151) 151
rosiglitazone (151) 151
dosage and administration (150) 150
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3503) 3503
German (173) 173
French (93) 93
Japanese (52) 52
Italian (46) 46
Russian (45) 45
Spanish (44) 44
Polish (33) 33
Chinese (16) 16
Hungarian (11) 11
Portuguese (10) 10
Czech (9) 9
Danish (9) 9
Swedish (6) 6
Dutch (5) 5
Finnish (4) 4
Bulgarian (3) 3
Croatian (3) 3
Hebrew (3) 3
Norwegian (3) 3
Ukrainian (3) 3
Serbian (2) 2
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9840, pp. 475 - 483
Summary Background Addition of a sulphonylurea to metformin improves glycaemic control in type 2 diabetes, but is associated with hypoglycaemia and weight... 
Internal Medicine | ALL-CAUSE MORTALITY | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | ADD-ON | METAANALYSIS | GLUCOSE CONTROL | CARDIOVASCULAR-DISEASE | HYPOGLYCEMIA | RISK | MELLITUS | ASSOCIATION | Metformin - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Purines - administration & dosage | Hypoglycemic Agents - administration & dosage | Treatment Failure | Adult | Female | Quinazolines - administration & dosage | Linagliptin | Purines - adverse effects | Purines - therapeutic use | Sulfonylurea Compounds - administration & dosage | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Sulfonylurea Compounds - therapeutic use | Treatment Outcome | Sulfonylurea Compounds - adverse effects | Diabetes Mellitus, Type 2 - blood | Quinazolines - therapeutic use | Quinazolines - adverse effects | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Research Design | Type 2 diabetes | Complications and side effects | Dosage and administration | Metformin | Drug therapy | Hypoglycemic sulfonylureas | Sulfonylurea compounds | Glimepiride | Comparative analysis | Heart attacks | Diabetes | Pharmaceutical industry | Drug dosages | Index Medicus | Abridged Index Medicus | Drugs | Obesity | Body weight | Diabetes mellitus
Journal Article
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 10/2009, Volume 52, Issue 10, pp. 2046 - 2055
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9681, pp. 2125 - 2135
Summary Background Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people... 
Internal Medicine | CARDIAC OUTCOMES | METFORMIN | MEDICINE, GENERAL & INTERNAL | MONOTHERAPY | MYOCARDIAL-INFARCTION | SULFONYLUREAS | HEART-ASSOCIATION | RISK | COMPLICATIONS | BLOOD-GLUCOSE CONTROL | FAILURE | Glycated Hemoglobin A - analysis | Myocardial Infarction - mortality | Body Weight | Metformin - therapeutic use | Prospective Studies | Humans | Middle Aged | Fractures, Bone - epidemiology | Hospitalization - statistics & numerical data | Male | Drug Utilization | Thiazolidinediones - therapeutic use | Cholesterol, LDL - blood | Female | Stroke - mortality | Drug Therapy, Combination | Heart Failure - epidemiology | Hypoglycemic Agents - therapeutic use | Administration, Oral | Sulfonylurea Compounds - therapeutic use | Angina, Unstable - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sex Factors | Cholesterol, HDL - blood | Diuretics - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Neoplasms - epidemiology | Type 2 diabetes | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Metformin | Rosiglitazone maleate | Drug therapy | Health aspects | Heart failure | Studies | Clinical trials | Data collection | Blood pressure | Diabetes | Marketing | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Diabetes Care, ISSN 0149-5992, 11/2014, Volume 37, Issue 11, pp. 2926 - 2933
Journal Article